In The News Posted January 9, 2020 Share Posted January 9, 2020 BOSTON and MONTRÉAL, Jan. 9, 2020 /PRNewswire/ - enGene Inc., the biotechnology company developing rationally designed gene therapies targeted to mucosal tissues through its proprietary non-viral vector DDX® platform, today announced the appointments of Sharon Tan as Vice President and... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.